Eflornithine in Treating Patients With Bladder Cancer

NCT00003814 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

450

Enrollment

NIH

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: eflornithine

Sponsor

National Cancer Institute (NCI)